Evaluating Cinnamon Effects on Clinical, Serologic and Sonographic Characteristics of Non-Alcoholic Fatty Liver Disease patients

Deputy of Research Development Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Inclusion criteria (consenting NAFLD patients 18-65 years old; evidence of fatty liver in ultrasonography with a score of 2 or more or alanine aminotransferase (ALT) levels up to 60 U/L;) and exclusion criteria (daily alcohol consumption above 20 g in women and 30 g in men; incidence of other acute or chronic liver diseases (hepatitis B, C, etc); cirrhosis; biliary disease; known autoimmune disease; malignancy and/or inherited disorders that affect liver status (an iron storage disease, Wilson disease, etc); pregnancy and lactation; metformin consumption; incidence of hyperlipidemia or hypertension requiring medication; previous supplementation of vitamin E; usage of hepatotoxic drugs over the past 6 months prior to the trial; developing hypersensitivity to cinnamon or occurring any adverse effects; acquiring viral/autoimmune/metabolic hepatic disorders during the study; alcohol intake; withdrawing treatment or being lost to follow up clinical and para-clinical examinations)

发起方

Deputy of Research Development Ahvaz Jundishapur University of Medical Sciences